Skip to content
Subscriber Only

Sinopharm Says Shot 79% Effective and Seeks General Use in China

  • Efficacy rate is below levels shown by Pfizer, Moderna shots
  • Shot could be one of first in world approved for general use
Bloomberg business news
Watch: China approves the country’s first coronavirus vaccine for general public use. (Source: Bloomberg)
Updated on

State-backed vaccine developer China National Biotec Group Co. said one of its shots is effective in preventing Covid-19 in 79.3% of people, allowing it to apply for authorization to market the inoculation for use in the general population.

The interim data shows the vaccine, which is already authorized for emergency use in China, is safe and people who took the shots in the trial all generated high levels of antibodies, according to a statement posted on the website of Beijing Biological Products Institute Co., a subsidiary of CNBG’s parent Sinopharm.